Trial Profile

Prospective Single Center Trial to Compare 68Ga-PSMA-11 and Axumin PET/CT (18F-Fluciclovine) for Restaging Prostate Cancer Patients With Biochemical Recurrence After Radical Prostatectomy

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 31 May 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

29 May 2024 According to Blue Earth Diagnostics media release, data from this study will be presented in upcoming presentations by its collaborators at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, to be held June 8 to 11, 2024, in Toronto, Canada.
19 Oct 2022 According to Blue Earth Diagnostics media release, data from this study will be presented at the upcoming American Society for Radiation Oncology (ASTRO) 2022 Annual Meeting, from October 23 to 26, 2022.
31 May 2020 Results (n=787) of post hoc retrospective analysis from four studies (NCT02940262, NCT03515577, NCT04050215, NCT03582774) presented at the 56th Annual Meeting of the American Society of Clinical Oncology

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com